ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 52 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $23,000 | +4.5% | 10,730 | +0.6% | 0.00% | – |
| Q4 2017 | $22,000 | -60.0% | 10,665 | -11.1% | 0.00% | – |
| Q3 2017 | $55,000 | +111.5% | 11,997 | +0.7% | 0.00% | – |
| Q2 2017 | $26,000 | -36.6% | 11,916 | -9.0% | 0.00% | – |
| Q1 2017 | $41,000 | +51.9% | 13,095 | +23.8% | 0.00% | – |
| Q4 2016 | $27,000 | -34.1% | 10,580 | +0.3% | 0.00% | – |
| Q3 2016 | $41,000 | +46.4% | 10,545 | +0.1% | 0.00% | – |
| Q2 2016 | $28,000 | -78.9% | 10,531 | -19.0% | 0.00% | – |
| Q2 2014 | $133,000 | -22.2% | 13,001 | -8.9% | 0.00% | – |
| Q1 2014 | $171,000 | +26.7% | 14,272 | +19.8% | 0.00% | – |
| Q4 2013 | $135,000 | +12.5% | 11,910 | +6.7% | 0.00% | – |
| Q3 2013 | $120,000 | – | 11,167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,408,728 | $17,037,000 | 0.97% |
| WealthTrust Axiom LLC | 140,000 | $441,000 | 0.16% |
| Palo Alto Investors LP | 1,032,715 | $3,253,000 | 0.15% |
| SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $157,000 | 0.08% |
| Joel Isaacson & Co., LLC | 80,660 | $254,000 | 0.05% |
| Malaga Cove Capital, LLC | 10,250 | $31,000 | 0.02% |
| Cornerstone Capital, Inc. | 30,000 | $95,000 | 0.02% |
| Granahan Investment Management | 31,298 | $99,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 244,150 | $769,000 | 0.01% |
| Advisor Group, Inc. | 117,657 | $371,000 | 0.01% |